Metabolomic alterations in human cancer cells by Vitamin C-induced oxidative stress

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Uetaki, Megumi ^a   Tabata, Sho ^a   Nakasuka, Fumie ^a   Soga, Tomoyoshi ^a   Tomita, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

CELL SURVIVAL; DRUG EFFECTS; ENERGY METABOLISM; HUMAN; MCF-7 CELL LINE; METABOLISM; METABOLOME; METABOLOMICS; NEOPLASM; OXIDATIVE STRESS; PROCEDURES;

ASCORBIC ACID; CELL SURVIVAL; ENERGY METABOLISM; HUMANS; HYDROGEN PEROXIDE; MCF-7 CELLS; METABOLOME; METABOLOMICS; NAD; NEOPLASMS; OXIDATIVE STRESS;

EID: 84941278282     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13896     Document Type: Article

References (39)

1. Levine, M., Espey, M. G. and Chen, Q. Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment. Free Radic. Biol. Med. 47, 27-29, doi: 10.1016/j.freeradbiomed.2009.04.001 (2009).
2. Cameron, E. and Pauling, L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA 73, 3685-3689 (1976).
3. Cameron, E. and Pauling, L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA. 75, 4538-4542 (1978).
4. Creagan, E. T. et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N. Engl. J. Med. 301, 687-690, doi: 10.1056/NEJM197909273011303 (1979).
5. Moertel, C. G. et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N. Engl. J. Med. 312, 137-141, doi: 10.1056/NEJM198501173120301 (1985).
6. Chen, Q. et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. USA 102, 13604-13609, doi: 10.1073/pnas.0506390102 (2005).
7. Chen, Q. et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc. Natl. Acad. Sci. USA. 104, 8749-8754, doi: 10.1073/pnas.0702854104 (2007).
8. Chen, Q. et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA 105, 11105-11109, doi: 10.1073/pnas.0804226105 (2008).
9. Du, J., Cullen, J. J. and Buettner, G. R. Ascorbic acid: Chemistry, biology and the treatment of cancer. Biochim. Biophys. Acta 1826, 443-457, doi: 10.1016/j.bbcan.2012.06.003 (2012).
10. Takemura, Y. et al. High dose of ascorbic acid induces cell death in mesothelioma cells. Biochem. Biophys. Res. Commun. 394, 249-253, doi: 10.1016/j.bbrc.2010.02.012 (2010).
11. Takahashi, A. et al. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8, 1291-1297, doi: 10.1038/ncb1491 (2006).
12. Du, J. et al. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin. Cancer Res. 16, 509-520, doi: 10.1158/1078- 0432.CCR-09-1713 (2010).
13. Roomi, M. W., House, D., Eckert-Maksic, M., Maksic, Z. B. and Tsao, C. S. Growth suppression of malignant leukemia cell line in vitro by ascorbic acid (vitamin C) and its derivatives. Cancer Lett. 122, 93-99 (1998).
14. Ramsey, M. R. and Sharpless, N. E. ROS as a tumour suppressor? Nat. Cell Biol. 8, 1213-1215 (2006).
15. Garrido, C. et al. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 13, 1423-1433 (2006).
16. Han, D., Antunes, F., Canali, R., Rettori, D. and Cadenas, E. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J. Biol. Chem. 278, 5557-5563, doi: 10.1074/jbc.M210269200 (2003).
17. Colussi, C. et al. H2O2-induced block of glycolysis as an active ADP-ribosylation reaction protecting cells from apoptosis. FASEB J. 14, 2266-2276, doi: 10.1096/fj.00-0074com (2000).
18. Buettner, G. R. Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med. Chem. 11, 341-346 (2011).
19. Chen, P. et al. Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anticancer Drugs 23, 437-444, doi: 10.1097/CAD.0b013e32834fd01f (2012).
20. Kim, J. et al. Enhanced antitumor activity of vitamin C via p53 in cancer cells. Free Radic. Biol. Med. 53, 1607-1615, doi: 10.1016/j.freeradbiomed.2012.07.079 (2012).
21. Hong, S. W. et al. SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment. Oncogene 32, 1508-1517, doi: 10.1038/ onc.2012.176 (2013).
22. Khurana, V., Kwatra, D., Pal, D. and Mitra, A. K. Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells. Int. J. Pharm. 474, 14-24, doi: 10.1016/j.ijpharm.2014.07.056 (2014).
23. Sinnberg, T. et al. The ROS-induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF-1alpha in the NCI60 cancer cell lines. J. Cell. Mol. Med. 18, 530-541, doi: 10.1111/jcmm.12207 (2014).
24. Cairns, R. A., Harris, I. S. and Mak, T. W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95, doi: 10.1038/nrc2981 (2011).
25. Soga, T. Cancer metabolism: key players in metabolic reprogramming. Cancer Sci. 104, 275-281, doi: 10.1111/cas.12085 (2013).
26. Hirayama, A. et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918-4925, doi: 10.1158/0008-5472.CAN-08-4806 (2009).
27. Irani, K. et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652 (1997).
28. Vafa, O. et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044 (2002).
29. Warburg, O. On the origin of cancer cells. Science 123, 309-314 (1956).
30. Levine, A. J. and Puzio-Kuter, A. M. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330, 1340-1344, doi: 10.1126/science.1193494 (2010).
31. Vander Heiden, M. G., Cantley, L. C. and Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033, doi: 10.1126/science.1160809 (2009).
32. Hanahan, D. and Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674, doi: 10.1016/j.cell.2011.02.013 (2011).
33. Locasale, J. W. and Cantley, L. C. Metabolic flux and the regulation of mammalian cell growth. Cell metabolism 14, 443-451, doi: 10.1016/j.cmet.2011.07.014 (2011).
34. Epner, D. E., Partin, A. W., Schalken, J. A., Isaacs, J. T. and Coffey, D. S. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. Cancer Res. 53, 1995-1997 (1993).
35. Revillion, F., Pawlowski, V., Hornez, L. and Peyrat, J. P. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. Eur. J. Cancer 36, 1038-1042 (2000).
36. Tokunaga, K. et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 47, 5616-5619 (1987).
37. Higashimura, Y. et al. Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells. Arch. Biochem. Biophys. 509, 1-8, doi: 10.1016/j.abb.2011.02.011 (2011).
38. Soga, T. et al. Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. Anal. Chem. 81, 6165-6174, doi: 10.1021/ac900675k (2009).
39. Sugimoto, M., Wong, D. T., Hirayama, A., Soga, T. and Tomita, M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics: Official journal of the Metabolomic Society 6, 78-95, doi: 10.1007/s11306-009-0178-y (2010).